Boundless Bio, Inc.
- BOLD
- NASDAQ
- Biotechnology
- Oncology Biotech (ecDNA)
- Cancer Therapeutics
$2.33
Today −0.43%Quote Oct 19, 2026, 02:34 PM UTC
−16.43%over the last month
Max drawdown −18.8%From 1-month high −18.8%3 months −4.1%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$53.0M
Quote Oct 19
Next earnings
Nov 5
Expected, not confirmed
Latest analyst target
—
Data unavailable
Floor
$2.19
6.0% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about BOLDPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
28
Founded
2018